November 14, 2005 - Quintiles Transnational today announced financial results for the quarter ended September 30, 2005. Net revenue for third quarter 2005 was $470.3 million, an increase of 19% from net revenue of $396.5 million for third quarter 2004.

November 10, 2005 - Quintiles Transnational Corp. has announced that it will conduct a live webcast of its third quarter 2005 earnings release conference call on Tuesday, Nov. 15, at 11:00 a.m. EST.

September 30, 2005 - Quintiles Transnational Corp. today announced the completion of the previously announced agreement with Aptuit, Inc., to enter a strategic partnership.

August 19, 2005 – Quintiles Transnational Corp. today announced that its newly formed subsidiary, Duloxetine Royalty Sub (“Royalty Sub”), intends to issue $150 million of Duloxetine Secured Notes, plus as much as $50 million to $150 million of additional notes, depending on market and other conditions.

August 12, 2005 - Quintiles Transnational today announced financial results for the quarter ended June 30, 2005. Net revenue for second quarter 2005 was $537.4 million, an increase of 26% from net revenue of $425.8 million for second quarter 2004.

August 9, 2005 - RESEARCH TRIANGLE PARK, N.C. – August 9, 2005 – Quintiles Transnational Corp. today announced that it will conduct a live webcast of its second quarter 2005 earnings release conference call on Friday, Aug. 12, at 1:00 p.m. EDT.

July 21, 2005 - Quintiles Transnational today announced the appointment of Kiyotaka Fujii as President and Chief Executive Officer of Quintiles Transnational Japan K.K. (Quintiles Japan) as of August 1, 2005.

July 19, 2005 - Quintiles Transnational Corp. announced today that it has signed an agreement with Aptuit Inc. to enter a strategic partnership. Aptuit will acquire three Quintiles business units – Preclinical Services, Pharmaceutical Sciences and Clinical Trial Supplies – for approximately $125 million, and the two companies will sign a two-year commercial agreement.

June 9, 2005 - Three global companies have announced a joint venture to commercialize pharmaceutical products in the Asia Pacific region. Partners in the joint venture include Interpharma Asia Pacific, Temasek Holdings and Quintiles Transnational Corp.

June 2, 2005 - Quintiles Transnational Corp. has announced that Quintiles Laboratories Asia has amended its existing agreement with Peking Union Medical College Hospital to enhance central laboratory services in China.

May 13, 2005 - Quintiles Transnational Corp. today announced financial results for the quarter ended March 31, 2005. Net revenue for first quarter 2005 was $492.4 million, an increase of 16% from net revenue of $423.2 million for the same quarter in 2004.

May 11, 2005 - Quintiles Transnational Corp. today announced that it will conduct a live webcast of its first quarter 2005 earnings release conference call on Monday, May 16, at 11:00 a.m. EDT.

March 7, 2005 - Quintiles Transnational Corp. today announced financial results for the year and quarter ended Dec. 31, 2004. Net revenue for 2004 was $1.78 billion versus $1.63 billion in 2003.

March 3, 2005 - Quintiles Transnational Corp. today announced that it will conduct a live webcast of its fourth quarter 2004 earnings release conference call on Wednesday, March 9, at 11:00 a.m. EST.

February 18, 2005 - Quintiles Inc., the North American clinical development subsidiary of Quintiles Transnational Corp., and the University of North Carolina at Chapel Hill have announced the creation of a new alliance for clinical research.